These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 27580190)

  • 21. What is known about community pharmacy supply of naloxone? A scoping review.
    Nielsen S; Van Hout MC
    Int J Drug Policy; 2016 Jun; 32():24-33. PubMed ID: 26949189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Losing the uphill battle? Emergent harm reduction interventions and barriers during the opioid overdose crisis in Canada.
    Strike C; Watson TM
    Int J Drug Policy; 2019 Sep; 71():178-182. PubMed ID: 30975595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Barriers to naloxone use and acceptance among opioid users, first responders, and emergency department providers in New Hampshire, USA.
    Bessen S; Metcalf SA; Saunders EC; Moore SK; Meier A; McLeman B; Walsh O; Marsch LA
    Int J Drug Policy; 2019 Dec; 74():144-151. PubMed ID: 31590090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Implementing an overdose education and naloxone distribution program in a health system.
    Devries J; Rafie S; Polston G
    J Am Pharm Assoc (2003); 2017; 57(2S):S154-S160. PubMed ID: 28233681
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increasing Naloxone Co-prescription for Patients on Chronic Opioids: a Student-Led Initiative.
    Freise JE; McCarthy EE; Guy M; Steiger S; Sheu L
    J Gen Intern Med; 2018 Jun; 33(6):797-798. PubMed ID: 29556799
    [No Abstract]   [Full Text] [Related]  

  • 26. Opioid education and nasal naloxone rescue kits in the emergency department.
    Dwyer K; Walley AY; Langlois BK; Mitchell PM; Nelson KP; Cromwell J; Bernstein E
    West J Emerg Med; 2015 May; 16(3):381-4. PubMed ID: 25987910
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emergency department naloxone distribution: a Rhode Island department of health, recovery community, and emergency department partnership to reduce opioid overdose deaths.
    Samuels E
    R I Med J (2013); 2014 Oct; 97(10):38-9. PubMed ID: 25271659
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is systematic training in opioid overdose prevention effective?
    Espelt A; Bosque-Prous M; Folch C; Sarasa-Renedo A; Majó X; Casabona J; Brugal MT;
    PLoS One; 2017; 12(10):e0186833. PubMed ID: 29088247
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Addressing the Fentanyl Threat to Public Health.
    Frank RG; Pollack HA
    N Engl J Med; 2017 Feb; 376(7):605-607. PubMed ID: 28199808
    [No Abstract]   [Full Text] [Related]  

  • 30. The role of managed care pharmacy in coprescribing naloxone for patients with specific risk: recommendations from the AMCP Addiction Advisory Group.
    Skelton JB; Dharbhamalla V
    J Manag Care Spec Pharm; 2022 Jan; 28(1):100-106. PubMed ID: 34949114
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identifying gaps in the implementation of naloxone programs for laypersons in the United States.
    Lambdin BH; Zibbell J; Wheeler E; Kral AH
    Int J Drug Policy; 2018 Feb; 52():52-55. PubMed ID: 29232604
    [No Abstract]   [Full Text] [Related]  

  • 32. 'It's too much, I'm getting really tired of it': Overdose response and structural vulnerabilities among harm reduction workers in community settings.
    Kolla G; Strike C
    Int J Drug Policy; 2019 Dec; 74():127-135. PubMed ID: 31590088
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reducing Fatal Opioid Overdose: Prevention, Treatment and Harm Reduction Strategies.
    Hawk KF; Vaca FE; D'Onofrio G
    Yale J Biol Med; 2015 Sep; 88(3):235-45. PubMed ID: 26339206
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fentanyl and the Evolving Opioid Epidemic: What Strategies Should Policy Makers Consider?
    Barry CL
    Psychiatr Serv; 2018 Jan; 69(1):100-103. PubMed ID: 28967324
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Public Health and Pharmacy Partnerships in Opioid Harm Reduction: Responding to Community Needs.
    Medina S; Tomaszewski R; Chhen S; Hanson A; Mueller A; Palombi LC
    Prog Community Health Partnersh; 2021; 15(1):37-46. PubMed ID: 33775959
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Review of Opioid Overdose Prevention and Naloxone Prescribing: Implications for Translating Community Programming Into Clinical Practice.
    Mueller SR; Walley AY; Calcaterra SL; Glanz JM; Binswanger IA
    Subst Abus; 2015; 36(2):240-53. PubMed ID: 25774771
    [TBL] [Abstract][Full Text] [Related]  

  • 37. From Peers to Lay Bystanders: Findings from a Decade of Naloxone Distribution in Pittsburgh, PA.
    Bennett AS; Bell A; Doe-Simkins M; Elliott L; Pouget E; Davis C
    J Psychoactive Drugs; 2018; 50(3):240-246. PubMed ID: 29424656
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Legal changes to increase access to naloxone for opioid overdose reversal in the United States.
    Davis CS; Carr D
    Drug Alcohol Depend; 2015 Dec; 157():112-20. PubMed ID: 26507172
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overdose Education and Naloxone Distribution in the San Francisco County Jail.
    Wenger LD; Showalter D; Lambdin B; Leiva D; Wheeler E; Davidson PJ; Coffin PO; Binswanger IA; Kral AH
    J Correct Health Care; 2019 Oct; 25(4):394-404. PubMed ID: 31672075
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Medical providers' knowledge and concerns about opioid overdose education and take-home naloxone rescue kits within Veterans Affairs health care medical treatment settings.
    Winograd RP; Davis CS; Niculete M; Oliva E; Martielli RP
    Subst Abus; 2017; 38(2):135-140. PubMed ID: 28486076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.